DNA methylation is one of the best characterized epigenetic modifications and changes in DNA methylation are associated with many biological processes. In higher organisms, a cell's phenotype, arising from alternative gene expression profiles, can be controlled at least in part by DNA methylation [
1]. To date, the most accepted hypothesis is that gene silencing is correlated with DNA methylation at the promoter regions of the genes, while hypomethylation at such regions is linked to gene activation. Genomic DNA methylation is generally stable in somatic cells but is known to undergo extensive reprogramming at various stages of mammalian development [
2-
5]. There are many studies demonstrating distinct methylation levels and profiles in different cell types [
6-
10]. For example, a study focused on identifying the differentially methylated regions (DMRs) between conventional CD4
+ T cell (Tconv) and regulatory T cell (Treg) identified more than 100 DMRs that are present mainly at cell type-specific genes, such as
FOXP3 and
IL2RA [
9]. Recent studies have provided strong evidence that DNA methylation is much more dynamic and flexible than previously believed and have identified mechanisms of active DNA demethylation in addition to the well-described DNA methylating mechanisms [
11-
14]. One recent study employing bisulphite conversion-based MethylC-seq, has identified promoter-distal regions as the major site of dynamic changes in DNA methylation levels during ES cell differentiation [
15]. Another study employed a customized genome-wide methylation profiling method dubbed CHARM (comprehensive high-throughput arrays for relative methylation), and discovered waves of change in DNA methylation at 4.6 million potentially methylated sites during normal blood cell differentiation [
16]. These and other studies provide evidence that DNA methylation of the mammalian genome is not only cell-type specific but also highly flexible and dynamic.
Circulating mature CD4
+ T cells are a highly flexible, mixed and dynamic population. The CD4
+ T cell population is a mixture of naive (CD44
-CD62L
+), memory/effector (CD44
+CD62L
+/-) and regulatory cells (CD4
+CD25
+). The relative proportions of these circulating cell types change naturally with age and upon encountering antigens. In responding to activation through interaction with antigen presenting cells, CD4
+ T cell undergo differentiation into numerous effector T helper cell types, such as Th1, Th2 and Th17, depending on the type of antigen encountered. As determined by the cell surface phenotypes and their functional characteristics, an increased proportion of T cells in elderly individuals is found to be highly differentiated as a consequence of repeated exposure to antigens and decreased production of naive T cells due to reduced thymopoiesis [
17,
18]. These events lead to a greater proportion of the CD4
+ T cells displaying an effector/memory phenotype. There have been numerous studies examining the role of DNA methylation in T cell activation and differentiation with a specific focus on individual genes. There is evidence that the level of DNA methylation changes at specific genes following T cell activation and differentiation. For example, reduced DNA methylation and stable DNase I hypersensitivity sites are observed at the
Ifng and
Il4 loci during Th1 and Th2 cell differentiation, respectively [
19,
20] and DNA methylation at the
FOXP3 locus is greatly diminished in Treg cells compared to undifferentiated naive T cells [
21-
25]. A study investigating the role of CD44 in EAE (experimental autoimmune encephalitomyelitis) revealed that CD44 promotes Th1/Th17 cell differentiation with hypomethylation at the
Ifng and
Il17a promoters, whereas deficiency of CD44 inhibits Th1/Th17 cell differentiation and simultaneously enhances Th2/Treg cell differentiation with hypermethylation of
Ifng and
Il17a and hypomethylation of
Il4 [
26]. Thus, there is ample evidence supporting the idea that DNA demethylation or hypomethylation occurs at individual genes during the process of T cell differentiation.
It has also been well demonstrated that there are major changes in gene expression within a short time of the commencement of T cell activation and the role of associated changes in chromatin structure and histone modifications have been described [
27]. A more surprising result was reported several years ago in relation to rapid changes in DNA methylation following T cell activation [
28]. The promoter-enhancer region of the interleukin 2 gene was shown to undergo DNA demethylation within 20 minutes of stimulation in a transgenic T cell model [
28]. This demethylation was shown to be DNA replication-independent and the authors proposed a possible active enzymatic mechanism although there were no clear candidate enzymes at that time [
28]. Using reporter plasmids, DNA demethylation was confirmed to be necessary and sufficient to enhance transcription of
Il2 [
28]. Another study has shown that DNA demethylation at a specific CpG site at the promoter-enhancer of
IL2 promotes the recruitment of
OCT1 to its binding site and is regarded as a key epigenetic event in
IL2 expression following CD4
+ T cell activation [
29].
DNA methylation is also known to be an age-dependent process occurring naturally in all cells/tissues in mammals. Hypermethylation is found in aging liver and sperm cells in rats and in humans [
30-
32]. In contrast, age-dependent hypomethylation in interspersed repetitive sequences is also observed [
33]. T cells produce less IL2 with age, and thus their function in elderly individuals is impaired [
34,
35]. On the other hand, decreased expression of the methyltransferases,
DNMT1 and
DNMT3a, is associated with increased expression of certain other genes in T cells during aging [
36]. Although age-related DNA methylation in T cells is less well-studied, several studies have focused on the changes in DNA methylation in memory T cells. Production of cytokines, such as IL2, is increased in memory CD8
+ T cells compared with naive cells and is correlated with DNA demethylation occurring at the promoters of these cytokine genes [
37,
38]. These studies have all provided evidence that DNA methylation status, specifically at the promoters of inducible genes, is altered during T cell differentiation, activation and development.
DNA methylation and demethylation are two opposing epigenetic processes in genome regulation and the balance between them may help determine the level of genomic methylation in a given cell type. The DNA methyltransferases are part of the DNA methylation machinery required for maintaining genome stability through methylation of appropriate genomic regions [
39]. These DNA methyltransferases, namely DNMT1, DNMT3a and DNMT3b, not only act as enzymes for maintaining genomic DNA methylation, but are also regarded as mediators of gene transcriptional silencing [
40].
In addition to the DNA methyltransferases, the discovery of novel enzymes involved in active DNA demethylation has led to the idea that there may be a balance in the methylating and demethylating enzymatic activities that determines the level of genomic DNA methylation in any given cell. Although DNA demethylation was initially thought to occur only during DNA replication [
41], active DNA demethylation has now been shown to occur independently of DNA replication and is involved in many developmental and physiological processes in animals and plants [
11,
12,
14]. In plants, active DNA demethylation is important in controlling the activity of the RNA-directed DNA methylation pathway, and thus preventing the spread of methylation from repetitive sequences to their neighbouring genes [
12]. In animals, several enzymatic complexes have recently been linked with active DNA demethylation [
11,
14]. Deaminases, including the AICDA and APOBEC family, are enzymes that catalyse the removal of -NH
2 from DNA, and are responsible for hypermutation of their target substrates [
42,
43]. Glycosylases, such as Methyl-CpG-binding protein 4 (MBD4) and thymine DNA glycosylase (TDG), have also been reported to be involved in base excision repair and repair of T:G mismatches. MBD4 is one of the known thymine glycosylases and binds preferentially to 5mCpG · TpG mismatches, followed by efficient removal of thymine or uracil from a mismatched CpG site
in vitro [
44]. These enzymatic activities are now thought to act in a novel pathway of DNA demethylation [
14]. A member of the Gadd45 family, Gadd45a, promotes the coupling process of an enzyme complex containing a cytosine deaminase, AICDA and a glycosylase, MBD4 [
43]. An interesting study using
Gadd45b knockout mice has recently revealed that GADD45b is required for activation-induced DNA demethylation of specific promoters and expression of corresponding genes critical for adult neurogenesis, including brain-derived neurotrophic factor and fibroblast growth factor [
45].
DNA demethylation also occurs during embryonic stem (ES) cell differentiation via the Ten-eleven-translocation enzymes (TET1, TET2 and TET3) that catalyse the conversion of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC) [
46,
47]. In addition to 5hmC, the TET enzymes are also capable of generating other minor products, such as 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC) [
48]. 5caC can be specifically recognised and repaired by thymine DNA glycosylase (TDG) [
49], one the enzymes involved in the GADD45/deaminase/glycosylase pathway mentioned above.
Given that the DNA methylation status of certain genes in T cells changes rapidly following cell activation and that differentiation leads to significant shifts in the gene expression profile, we have examined the changes that occur in DNA methylation at both the gene-specific and genome-wide level following activation and differentiation and have attempted to correlate this with changes in the enzymes known to be involved in DNA methylation and active demethylation.